Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992- 1995

Harvard Review of Psychiatry

Volumn 7, Issue 1, 1999, Pages 29-36

  Sclar, David A ^a,b   Robison, Linda M ^a   Skaer, Tracy L ^a,c   Galin, Richard S ^a,c,d  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Washington Institute for Mental Illness Research and Training   (United States)

^c Pullman Memorial Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CAUCASIAN; CONSULTATION; DEMOGRAPHY; DEPRESSION; DRUG UTILIZATION; ETHNIC GROUP; ETHNOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; NEGRO; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PREVALENCE; QUESTIONNAIRES; UNITED STATES;

EID: 0032836591     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.1093/hrp/7.1.29     Document Type: Article

References (51)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19.
2. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. Depression: a neglected major illness. J Clin Psychiatry 1993; 54:419-24.
3. Gazmararian JA, James SA, Lepkowski JM. Depression in black and white women: the role of marriage and socioeconomic status. Ann Epidemiol 1995;5:455-63.
4. Warren BJ. Depression in African-American women. J Psychosoc Nurs Ment Health Serv 1994;32:29-33.
5. Barbee EL. African American women and depression: a review and critique of the literature. Arch Psychiatr Nurs 1992;6: 257-65.
6. Garcia M, Marks G. Depressive symptomatology among Mexican-American adults: an examination with the CES-D scale. Psychiatry Res 1989;27:137-48.
7. Moscicki EK, Locke BZ, Rae DS, Boyd JH. Depressive symptoms among Mexican Americans: the Hispanic Health and Nutrition Examination Survey. Am J Epidemiol 1989;130: 348-60.
8. Narrow WE, Rae DS, Moscicki EK, Locke BZ, Regier DA. Depression among Cuban Americans: the Hispanic Health and Nutrition Examination Survey. Soc Psychiatry Psychiatr Epidemiol 1990;25:260-8.
9. Somervell PD, Leaf PJ, Weissman MM, Blazer DG, Bruce ML. The prevalence of major depression in black and white adults in five United States communities. Am J Epidemiol 1989; 130:725-35.
10. Hoppe SK, Leon RL, Realini JP. Depression and anxiety among Mexican Americans in a family health center. Soc Psychiatry Psychiatr Epidemiol 1989;24:63-8.
11. Golding JM, Karno M, Rutter CM. Symptoms of major depression among Mexican-Americans and non-Hispanic whites. Am J Psychiatry 1990;147:861-6.
12. Burvill PW. Recent progress in the epidemiology of major depression. Epidemiol Rev 1995;17:21-31.
13. Neighbors HW, Lumpkin S. The epidemiology of mental disorder in the black population. In: Ruiz DS, ed. Handbook of mental health and mental disorder among black Americans. Westport, Connecticut: Greenwood, 1990:55-70.
14. Karno M, Hough RL, Burnam MA, Escobar JI, Timbers DM, Santana F, et al. Lifetime prevalence of specific psychiatric disorders among Mexican Americans and non-Hispanic whites in Los Angeles. Arch Gen Psychiatry 1987;44:695-701.
15. Callahan CM, Wolinsky FD. The effect of gender and race on the measurement properties of the CES-D in older adults. Med Care 1994;32:341-56.
16. Golding JM, Aneshensel CS, Hough RL. Responses to Depression Scale items among Mexican-Americans and non-Hispanic whites. J Clin Psychol 1991;47:61-75.
17. Guarnaccia PJ, Angel R, Worobey JL. The factor structure of the CES-D in the Hispanic Health and Nutrition Examination Survey: the influences of ethnicity, gender and language. Soc Sci Med 1989;29:85-94.
18. Adebimpe VR. Race, racism, and epidemiological surveys. Hosp Community Psychiatry 1994;45:27-31.
19. Lee AJ, Gehlbach S, Hosmer D, Reti M, Baker CS. Medicare treatment differences for blacks and whites. Med Care 1997; 35:1173-89.
20. Lim HL. A practical approach to the management of depression. Singapore Med J 1993;34:449-51.
21. Campbell LK, Robison LM, Skaer TL, Sclar DA. Depression: interventions and their effectiveness. Dis Manage Health Outcomes 1997;2:223-37.
22. Olfson M, Klerman GL. The treatment of depression: prescribing practices of primary care physicians and psychiatrists. J Fam Pract 1992;35:627-35.
23. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry 1993; 150:571-7.
24. Sclar DA, Robison LM, Skaer TL, Galin RS. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits 1990-1995. Clin Ther 1998;20:871-84.
25. Andrews JM, Nemeroff CB. Contemporary management of depression. Am J Med 1994;97(suppl 6A):24-32S.
26. Nemeroff CB. Evolutionary trends in the pharmacotherapeutic management of depression. J Clin Psychiatry 1994;55 (suppl):3-15.
27. Stokes PE, Holtz A. Fluoxetine tenth anniversary update: the progress continues. Clin Ther 1997;19:1135-250.
28. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 1995;56(suppl 6):12-21.
29. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705-13.
30. Nelson JC. Are the SSRIs really better tolerated than the TCAs for treatment of major depression? Psychiatr Ann 1994; 24:628-31.
31. DeVane CL. Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 1994;97(suppl 6A):13-23S.
32. Brown DR, Ahmed F, Gary LE, Milburn NG. Major depression in a community sample of African Americans. Am J Psychiatry 1995;152:373-8.
33. Brown SL, Salive ME, Guralnik JM, Pahor M, Chapman DP, Blazer D. Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization. J Clin Epidemiol 1995;48:445-53.
34. Rosenheck R, Fontana A, Cottrol C. Effect of clinician-veteran racial pairing in the treatment of posttraumatic stress disorder. Am J Psychiatry 1995;152:555-63.
35. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE. Antidepressant prescribing patterns: a comparison of blacks and whites in a Medicaid population. Clin Drug Invest 1998;16:135-40.
36. Schappert SM. National Ambulatory Medical Care Survey: 1992 summary [Advance Data from Vital and Health Statistics no 253]. Hyattsville, Maryland: National Center for Health Statistics, 1994.
37. Schappert SM. National Ambulatory Medical Care Survey: 1994 summary [Advance Data from Vital and Health Statistics no 273]. Hyattsville, Maryland: National Center for Health Statistics, 1996.
38. Woodwell DW, Schappert SM. National Ambulatory Medical Care Survey: 1993 summary [Advance Data from Vital and Health Statistics no 270]. Hyattsville, Maryland: National Center for Health Statistics, 1995.
39. Woodwell DA. National Ambulatory Medical Care Survey: 1995 summary [Advance Data from Vital and Health Statistics no 286]. Hyattsville, Maryland: National Center for Health Statistics, 1997.
40. Bryant E, Shimizu I. Sampling design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. Vital Health Stat 2 1988;108:1-39.
41. The international classification of diseases, 9th revision, clinical modification, vol 1. 3rd ed. Washington, DC: US Department of Health and Human Services, 1989.
42. US Food and Drug Administration. National drug code directory. 1985 ed. Washington, DC: Public Health Service, 1985.
43. US Food and Drug Administration. National drug code directory. 1995 ed. Washington, DC: Public Health Service, 1995.
44. Koch H, Campbell WH. The collection and processing of drug information: National Ambulatory Medical Care Survey, United States, 1980. Vital Health Stat 2 1982;2(90):1-90.
45. Statistical export and tabulation system 1.22a: users reference manual. Hyattsville, Maryland: United States Department of Health and Human Services, National Center for Health Statistics, 1991.
46. US Census Bureau. National population estimates for the 1990's. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. [Available from http:// www.census.gov/population/www/estimates/nat_90s_1.html; published 22 February 1998.]
47. Sramek JJ, Pi EH. Ethnicity and antidepressant response. Mt Sinai J Med 1996;63:320-5.
48. Risby ED. Ethnic considerations in the pharmacotherapy of mood disorders. Psychopharmacol Bull 1996;32:231-4.
49. Lin KM, Poland RE. Ethnicity, culture, and psychopharmacology. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven, 1995: 1907-17.
50. Lawson WB. Clinical issues in the pharmacotherapy of African-Americans. Psychopharmacol Bull 1996;32:275-81.
51. Lawson WB. The art and science of the psychopharmacotherapy of African Americans. Mt Sinai J Med 1996;63:301-5.